With roots dating to 1997, Shenzhen Haorui Pharmatech supplies a broad portfolio of active pharmaceutical ingredients spanning anti-infectives (levofloxacin, linezolid, tigecycline, anidulafungin, rifaximin), immunosuppressants and specialty drugs (tacrolimus, rocuronium bromide, relugolix, sitagliptin), and emerging therapeutics such as orforglipron, alongside veterinary APIs and nutritional/health-product raw materials. The company offers CMO and CDMO contract manufacturing and distributes to customers across North America, Europe, Asia, the Middle East, and Africa.
No hay comentarios disponibles.
Deja tu valoración & comentario